173 related articles for article (PubMed ID: 6269703)
21. Effect of apomorphine plus 5-hydroxytryptophan on plasma prolactin levels in male rats.
Meltzer HY; Fang VS
Psychopharmacol Commun; 1976; 2(3):189-98. PubMed ID: 1087036
[TBL] [Abstract][Full Text] [Related]
22. [The effect of lithium treatment on the activity of central dopaminergic neurons].
Koyama T
Hokkaido Igaku Zasshi; 1987 May; 62(3):402-16. PubMed ID: 3111963
[TBL] [Abstract][Full Text] [Related]
23. Time-dependent increase in plasma prolactin after pituitary stalk section: role of posterior pituitary dopamine.
Murai I; Garris PA; Ben-Jonathan N
Endocrinology; 1989 May; 124(5):2343-9. PubMed ID: 2495929
[TBL] [Abstract][Full Text] [Related]
24. [Dependence of the effects of tripeptide MIF and lithium chloride on the degree of supersensitivity of dopamine receptors of the brain].
Bondarenko NA; Val'dman AV
Biull Eksp Biol Med; 1989 Aug; 108(8):196-9. PubMed ID: 2553154
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of hypophysectomy-induced dopamine receptor hypersensitivity in male rats by chronic haloperidol administration.
Gordon JH; Diamond BI
J Neurochem; 1984 Feb; 42(2):523-8. PubMed ID: 6537969
[TBL] [Abstract][Full Text] [Related]
26. Effect of chronic treatment with haloperidol on serum prolactin, striatal opiate receptors and beta-endorphin content in rat brain and pituitary.
Kato N; Shah KR; Friesen HG; Havlicek V
Prog Neuropsychopharmacol; 1981; 5(5-6):549-52. PubMed ID: 6280225
[No Abstract] [Full Text] [Related]
27. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro effects of tetrahydroisoquinolines and other alkaloids on rat pituitary function.
Britton DR; Rivier C; Shier T; Bloom F; Vale W
Biochem Pharmacol; 1982 Apr; 31(7):1205-11. PubMed ID: 6284172
[TBL] [Abstract][Full Text] [Related]
29. Etomidate inhibits prolactin release but not through a dopaminergic mechanism.
Preziosi P; Cerrito F; Vacca M
Brain Res; 1983 Jul; 271(2):379-85. PubMed ID: 6604560
[TBL] [Abstract][Full Text] [Related]
30. Desenkephalin-gamma-endorphin restores the impaired sensitivity of hypophysectomized rats to small doses of apomorphine.
Drago F; Van Ree JM; De Wied D
Eur J Pharmacol; 1986 Sep; 128(3):205-12. PubMed ID: 3792442
[TBL] [Abstract][Full Text] [Related]
31. Postreceptorial refractoriness of prolactin release mechanisms.
Collu R; Ducharme JR; Eljarmak D; Marchisio AM; Bertrand J; Sabbagh I; Guillaumot P; Cohen H
Can J Physiol Pharmacol; 1983 Jul; 61(7):676-84. PubMed ID: 6616329
[TBL] [Abstract][Full Text] [Related]
32. Opposite interactions between alpha- and beta-endorphin fragments with dopamine mediated responses on the rat rectum in vitro.
Nijkamp FP; van Ree JM; Nijssen JG; Versluis M; de Wied D
Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):213-7. PubMed ID: 6185856
[TBL] [Abstract][Full Text] [Related]
33. Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration.
Parati EA; Parenti M; Locatelli V; Penalva A; Tamminga C; Müller EE
Pharmacol Res Commun; 1985 May; 17(5):407-15. PubMed ID: 4034625
[TBL] [Abstract][Full Text] [Related]
34. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro.
Meltzer HY; Simonovic M; Gudelsky GA
Eur J Pharmacol; 1983 Aug; 92(1-2):83-9. PubMed ID: 6628538
[TBL] [Abstract][Full Text] [Related]
35. Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies.
Hentschel K; Fleckenstein AE; Toney TW; Lawson DM; Moore KE; Lookingland KJ
Brain Res; 2000 Jan; 852(1):28-36. PubMed ID: 10661492
[TBL] [Abstract][Full Text] [Related]
36. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
Canonico PL; Valdenegro CA; MacLeod RM
Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
[TBL] [Abstract][Full Text] [Related]
37. Effects of phencyclidine on 5-hydroxytryptophan- and suckling-induced prolactin release.
Hyde JF
Brain Res; 1992 Feb; 573(2):204-8. PubMed ID: 1504760
[TBL] [Abstract][Full Text] [Related]
38. Opioid and dopamine involvement in prolactin release induced by arginine vasotocin and vasopressin in the male rat.
Blask DE; Vaughan MK; Champney TH; Johnson LY; Vaughan GM; Becker RA; Reiter RJ
Neuroendocrinology; 1984 Jan; 38(1):56-61. PubMed ID: 6694785
[TBL] [Abstract][Full Text] [Related]
39. Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats.
Leadem CA; Kalra SP
Neuroendocrinology; 1985 Oct; 41(4):342-52. PubMed ID: 4047342
[TBL] [Abstract][Full Text] [Related]
40. Paraventricular nucleus mediates prolactin secretory responses to restraint stress, ether stress, and 5-hydroxy-L-tryptophan injection in the rat.
Minamitani N; Minamitani T; Lechan RM; Bollinger-Gruber J; Reichlin S
Endocrinology; 1987 Mar; 120(3):860-7. PubMed ID: 3542515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
